0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Glycomics & Glycobiology- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Published Date: August 2025
|
Report Code: QYRE-Auto-36Y9062
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Glycomics Glycobiology Market Size Status and Forecast 2022
BUY CHAPTERS

Glycomics & Glycobiology- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Code: QYRE-Auto-36Y9062
Report
August 2025
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Glycomics & Glycobiology- Market Size

The global market for Glycomics & Glycobiology was estimated to be worth US$ 1419 million in 2024 and is forecast to a readjusted size of US$ 3008 million by 2031 with a CAGR of 11.5% during the forecast period 2025-2031.

Glycomics & Glycobiology- Market

Glycomics & Glycobiology- Market

Glycomics is the comprehensive study of glycomes (the entire complement of sugars, whether free or present in more complex molecules of an organism), including genetic, physiologic, pathologic, and other aspects. Glycomics "is the systematic study of all glycan structures of a given cell type or organism" and is a subset of glycobiology. The term glycomics is derived from the chemical prefix for sweetness or a sugar, "glyco-", and was formed to follow the naming convention established by genomics (which deals with genes) and proteomics (which deals with proteins).
Glycobiology is fast emerging as a primary field of interest for biomolecular and biomedical research around the globe. Once considered merely supporting structures, the sugars have now been widely recognized to be a vital component in running the complex machinery of life itself.
Global Glycomics/Glycobiology key players include ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, etc. Global top four manufacturers hold a share over 15%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Instruments is the largest segment, with a share about 33%. And in terms of application, the largest application is Drug Discovery & Development, followed by Diagnostics, etc.
This report aims to provide a comprehensive presentation of the global market for Glycomics & Glycobiology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Glycomics & Glycobiology by region & country, by Type, and by Application.
The Glycomics & Glycobiology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glycomics & Glycobiology.
Market Segmentation

Scope of Glycomics & Glycobiology- Market Report

Report Metric Details
Report Name Glycomics & Glycobiology- Market
Forecasted market size in 2031 US$ 3008 million
CAGR 11.5%
Forecasted years 2025 - 2031
Segment by Type
  • Instruments
  • Enzymes
  • Reagents
  • Kits
Segment by Application
  • Drug Discovery & Development
  • Diagnostics
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, Takara Bio, Inc., Agilent Technologies, Bruker, Promega, Waters Corporation, R&D Systems, New England Biolabs, Merck KGaA
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Glycomics & Glycobiology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Glycomics & Glycobiology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Glycomics & Glycobiology in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Glycomics & Glycobiology- Market size in 2031?

Ans: The Glycomics & Glycobiology- Market size in 2031 will be US$ 3008 million.

What is the market share of major companies in Glycomics & Glycobiology- Market?

Ans: Global top four manufacturers hold a share over 15%.

What is the Glycomics & Glycobiology- Market share by type?

Ans: In terms of product, Instruments is the largest segment, with a share about 33%.

Who are the main players in the Glycomics & Glycobiology- Market report?

Ans: The main players in the Glycomics & Glycobiology- Market are ThermoFisher Scientific, Danaher, Shimadzu Corporation, ProZyme, Takara Bio, Inc., Agilent Technologies, Bruker, Promega, Waters Corporation, R&D Systems, New England Biolabs, Merck KGaA

What are the Application segmentation covered in the Glycomics & Glycobiology- Market report?

Ans: The Applications covered in the Glycomics & Glycobiology- Market report are Drug Discovery & Development, Diagnostics, Others

What are the Type segmentation covered in the Glycomics & Glycobiology- Market report?

Ans: The Types covered in the Glycomics & Glycobiology- Market report are Instruments, Enzymes, Reagents, Kits

1 Market Overview
1.1 Glycomics & Glycobiology Product Introduction
1.2 Global Glycomics & Glycobiology Market Size Forecast (2020-2031)
1.3 Glycomics & Glycobiology Market Trends & Drivers
1.3.1 Glycomics & Glycobiology Industry Trends
1.3.2 Glycomics & Glycobiology Market Drivers & Opportunity
1.3.3 Glycomics & Glycobiology Market Challenges
1.3.4 Glycomics & Glycobiology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Glycomics & Glycobiology Players Revenue Ranking (2024)
2.2 Global Glycomics & Glycobiology Revenue by Company (2020-2025)
2.3 Key Companies Glycomics & Glycobiology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Glycomics & Glycobiology Product Offered
2.5 Key Companies Time to Begin Mass Production of Glycomics & Glycobiology
2.6 Glycomics & Glycobiology Market Competitive Analysis
2.6.1 Glycomics & Glycobiology Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Glycomics & Glycobiology Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycomics & Glycobiology as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Instruments
3.1.2 Enzymes
3.1.3 Reagents
3.1.4 Kits
3.2 Global Glycomics & Glycobiology Sales Value by Type
3.2.1 Global Glycomics & Glycobiology Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Glycomics & Glycobiology Sales Value, by Type (2020-2031)
3.2.3 Global Glycomics & Glycobiology Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Drug Discovery & Development
4.1.2 Diagnostics
4.1.3 Others
4.2 Global Glycomics & Glycobiology Sales Value by Application
4.2.1 Global Glycomics & Glycobiology Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Glycomics & Glycobiology Sales Value, by Application (2020-2031)
4.2.3 Global Glycomics & Glycobiology Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Glycomics & Glycobiology Sales Value by Region
5.1.1 Global Glycomics & Glycobiology Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Glycomics & Glycobiology Sales Value by Region (2020-2025)
5.1.3 Global Glycomics & Glycobiology Sales Value by Region (2026-2031)
5.1.4 Global Glycomics & Glycobiology Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Glycomics & Glycobiology Sales Value, 2020-2031
5.2.2 North America Glycomics & Glycobiology Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Glycomics & Glycobiology Sales Value, 2020-2031
5.3.2 Europe Glycomics & Glycobiology Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Glycomics & Glycobiology Sales Value, 2020-2031
5.4.2 Asia Pacific Glycomics & Glycobiology Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Glycomics & Glycobiology Sales Value, 2020-2031
5.5.2 South America Glycomics & Glycobiology Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Glycomics & Glycobiology Sales Value, 2020-2031
5.6.2 Middle East & Africa Glycomics & Glycobiology Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Glycomics & Glycobiology Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Glycomics & Glycobiology Sales Value, 2020-2031
6.3 United States
6.3.1 United States Glycomics & Glycobiology Sales Value, 2020-2031
6.3.2 United States Glycomics & Glycobiology Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Glycomics & Glycobiology Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Glycomics & Glycobiology Sales Value, 2020-2031
6.4.2 Europe Glycomics & Glycobiology Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Glycomics & Glycobiology Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Glycomics & Glycobiology Sales Value, 2020-2031
6.5.2 China Glycomics & Glycobiology Sales Value by Type (%), 2024 VS 2031
6.5.3 China Glycomics & Glycobiology Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Glycomics & Glycobiology Sales Value, 2020-2031
6.6.2 Japan Glycomics & Glycobiology Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Glycomics & Glycobiology Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Glycomics & Glycobiology Sales Value, 2020-2031
6.7.2 South Korea Glycomics & Glycobiology Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Glycomics & Glycobiology Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Glycomics & Glycobiology Sales Value, 2020-2031
6.8.2 Southeast Asia Glycomics & Glycobiology Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Glycomics & Glycobiology Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Glycomics & Glycobiology Sales Value, 2020-2031
6.9.2 India Glycomics & Glycobiology Sales Value by Type (%), 2024 VS 2031
6.9.3 India Glycomics & Glycobiology Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 ThermoFisher Scientific
7.1.1 ThermoFisher Scientific Profile
7.1.2 ThermoFisher Scientific Main Business
7.1.3 ThermoFisher Scientific Glycomics & Glycobiology Products, Services and Solutions
7.1.4 ThermoFisher Scientific Glycomics & Glycobiology Revenue (US$ Million) & (2020-2025)
7.1.5 ThermoFisher Scientific Recent Developments
7.2 Danaher
7.2.1 Danaher Profile
7.2.2 Danaher Main Business
7.2.3 Danaher Glycomics & Glycobiology Products, Services and Solutions
7.2.4 Danaher Glycomics & Glycobiology Revenue (US$ Million) & (2020-2025)
7.2.5 Danaher Recent Developments
7.3 Shimadzu Corporation
7.3.1 Shimadzu Corporation Profile
7.3.2 Shimadzu Corporation Main Business
7.3.3 Shimadzu Corporation Glycomics & Glycobiology Products, Services and Solutions
7.3.4 Shimadzu Corporation Glycomics & Glycobiology Revenue (US$ Million) & (2020-2025)
7.3.5 Shimadzu Corporation Recent Developments
7.4 ProZyme
7.4.1 ProZyme Profile
7.4.2 ProZyme Main Business
7.4.3 ProZyme Glycomics & Glycobiology Products, Services and Solutions
7.4.4 ProZyme Glycomics & Glycobiology Revenue (US$ Million) & (2020-2025)
7.4.5 ProZyme Recent Developments
7.5 Takara Bio, Inc.
7.5.1 Takara Bio, Inc. Profile
7.5.2 Takara Bio, Inc. Main Business
7.5.3 Takara Bio, Inc. Glycomics & Glycobiology Products, Services and Solutions
7.5.4 Takara Bio, Inc. Glycomics & Glycobiology Revenue (US$ Million) & (2020-2025)
7.5.5 Takara Bio, Inc. Recent Developments
7.6 Agilent Technologies
7.6.1 Agilent Technologies Profile
7.6.2 Agilent Technologies Main Business
7.6.3 Agilent Technologies Glycomics & Glycobiology Products, Services and Solutions
7.6.4 Agilent Technologies Glycomics & Glycobiology Revenue (US$ Million) & (2020-2025)
7.6.5 Agilent Technologies Recent Developments
7.7 Bruker
7.7.1 Bruker Profile
7.7.2 Bruker Main Business
7.7.3 Bruker Glycomics & Glycobiology Products, Services and Solutions
7.7.4 Bruker Glycomics & Glycobiology Revenue (US$ Million) & (2020-2025)
7.7.5 Bruker Recent Developments
7.8 Promega
7.8.1 Promega Profile
7.8.2 Promega Main Business
7.8.3 Promega Glycomics & Glycobiology Products, Services and Solutions
7.8.4 Promega Glycomics & Glycobiology Revenue (US$ Million) & (2020-2025)
7.8.5 Promega Recent Developments
7.9 Waters Corporation
7.9.1 Waters Corporation Profile
7.9.2 Waters Corporation Main Business
7.9.3 Waters Corporation Glycomics & Glycobiology Products, Services and Solutions
7.9.4 Waters Corporation Glycomics & Glycobiology Revenue (US$ Million) & (2020-2025)
7.9.5 Waters Corporation Recent Developments
7.10 R&D Systems
7.10.1 R&D Systems Profile
7.10.2 R&D Systems Main Business
7.10.3 R&D Systems Glycomics & Glycobiology Products, Services and Solutions
7.10.4 R&D Systems Glycomics & Glycobiology Revenue (US$ Million) & (2020-2025)
7.10.5 R&D Systems Recent Developments
7.11 New England Biolabs
7.11.1 New England Biolabs Profile
7.11.2 New England Biolabs Main Business
7.11.3 New England Biolabs Glycomics & Glycobiology Products, Services and Solutions
7.11.4 New England Biolabs Glycomics & Glycobiology Revenue (US$ Million) & (2020-2025)
7.11.5 New England Biolabs Recent Developments
7.12 Merck KGaA
7.12.1 Merck KGaA Profile
7.12.2 Merck KGaA Main Business
7.12.3 Merck KGaA Glycomics & Glycobiology Products, Services and Solutions
7.12.4 Merck KGaA Glycomics & Glycobiology Revenue (US$ Million) & (2020-2025)
7.12.5 Merck KGaA Recent Developments
8 Industry Chain Analysis
8.1 Glycomics & Glycobiology Industrial Chain
8.2 Glycomics & Glycobiology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Glycomics & Glycobiology Sales Model
8.5.2 Sales Channel
8.5.3 Glycomics & Glycobiology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Glycomics & Glycobiology Market Trends
 Table 2. Glycomics & Glycobiology Market Drivers & Opportunity
 Table 3. Glycomics & Glycobiology Market Challenges
 Table 4. Glycomics & Glycobiology Market Restraints
 Table 5. Global Glycomics & Glycobiology Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Glycomics & Glycobiology Revenue Market Share by Company (2020-2025)
 Table 7. Key Companies Glycomics & Glycobiology Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Glycomics & Glycobiology Product Type
 Table 9. Key Companies Time to Begin Mass Production of Glycomics & Glycobiology
 Table 10. Global Glycomics & Glycobiology Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glycomics & Glycobiology as of 2024)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Glycomics & Glycobiology Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 14. Global Glycomics & Glycobiology Sales Value by Type (2020-2025) & (US$ Million)
 Table 15. Global Glycomics & Glycobiology Sales Value by Type (2026-2031) & (US$ Million)
 Table 16. Global Glycomics & Glycobiology Sales Market Share in Value by Type (2020-2025)
 Table 17. Global Glycomics & Glycobiology Sales Market Share in Value by Type (2026-2031)
 Table 18. Global Glycomics & Glycobiology Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 19. Global Glycomics & Glycobiology Sales Value by Application (2020-2025) & (US$ Million)
 Table 20. Global Glycomics & Glycobiology Sales Value by Application (2026-2031) & (US$ Million)
 Table 21. Global Glycomics & Glycobiology Sales Market Share in Value by Application (2020-2025)
 Table 22. Global Glycomics & Glycobiology Sales Market Share in Value by Application (2026-2031)
 Table 23. Global Glycomics & Glycobiology Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 24. Global Glycomics & Glycobiology Sales Value by Region (2020-2025) & (US$ Million)
 Table 25. Global Glycomics & Glycobiology Sales Value by Region (2026-2031) & (US$ Million)
 Table 26. Global Glycomics & Glycobiology Sales Value by Region (2020-2025) & (%)
 Table 27. Global Glycomics & Glycobiology Sales Value by Region (2026-2031) & (%)
 Table 28. Key Countries/Regions Glycomics & Glycobiology Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 29. Key Countries/Regions Glycomics & Glycobiology Sales Value, (2020-2025) & (US$ Million)
 Table 30. Key Countries/Regions Glycomics & Glycobiology Sales Value, (2026-2031) & (US$ Million)
 Table 31. ThermoFisher Scientific Basic Information List
 Table 32. ThermoFisher Scientific Description and Business Overview
 Table 33. ThermoFisher Scientific Glycomics & Glycobiology Products, Services and Solutions
 Table 34. Revenue (US$ Million) in Glycomics & Glycobiology Business of ThermoFisher Scientific (2020-2025)
 Table 35. ThermoFisher Scientific Recent Developments
 Table 36. Danaher Basic Information List
 Table 37. Danaher Description and Business Overview
 Table 38. Danaher Glycomics & Glycobiology Products, Services and Solutions
 Table 39. Revenue (US$ Million) in Glycomics & Glycobiology Business of Danaher (2020-2025)
 Table 40. Danaher Recent Developments
 Table 41. Shimadzu Corporation Basic Information List
 Table 42. Shimadzu Corporation Description and Business Overview
 Table 43. Shimadzu Corporation Glycomics & Glycobiology Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Glycomics & Glycobiology Business of Shimadzu Corporation (2020-2025)
 Table 45. Shimadzu Corporation Recent Developments
 Table 46. ProZyme Basic Information List
 Table 47. ProZyme Description and Business Overview
 Table 48. ProZyme Glycomics & Glycobiology Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Glycomics & Glycobiology Business of ProZyme (2020-2025)
 Table 50. ProZyme Recent Developments
 Table 51. Takara Bio, Inc. Basic Information List
 Table 52. Takara Bio, Inc. Description and Business Overview
 Table 53. Takara Bio, Inc. Glycomics & Glycobiology Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Glycomics & Glycobiology Business of Takara Bio, Inc. (2020-2025)
 Table 55. Takara Bio, Inc. Recent Developments
 Table 56. Agilent Technologies Basic Information List
 Table 57. Agilent Technologies Description and Business Overview
 Table 58. Agilent Technologies Glycomics & Glycobiology Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Glycomics & Glycobiology Business of Agilent Technologies (2020-2025)
 Table 60. Agilent Technologies Recent Developments
 Table 61. Bruker Basic Information List
 Table 62. Bruker Description and Business Overview
 Table 63. Bruker Glycomics & Glycobiology Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Glycomics & Glycobiology Business of Bruker (2020-2025)
 Table 65. Bruker Recent Developments
 Table 66. Promega Basic Information List
 Table 67. Promega Description and Business Overview
 Table 68. Promega Glycomics & Glycobiology Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Glycomics & Glycobiology Business of Promega (2020-2025)
 Table 70. Promega Recent Developments
 Table 71. Waters Corporation Basic Information List
 Table 72. Waters Corporation Description and Business Overview
 Table 73. Waters Corporation Glycomics & Glycobiology Products, Services and Solutions
 Table 74. Revenue (US$ Million) in Glycomics & Glycobiology Business of Waters Corporation (2020-2025)
 Table 75. Waters Corporation Recent Developments
 Table 76. R&D Systems Basic Information List
 Table 77. R&D Systems Description and Business Overview
 Table 78. R&D Systems Glycomics & Glycobiology Products, Services and Solutions
 Table 79. Revenue (US$ Million) in Glycomics & Glycobiology Business of R&D Systems (2020-2025)
 Table 80. R&D Systems Recent Developments
 Table 81. New England Biolabs Basic Information List
 Table 82. New England Biolabs Description and Business Overview
 Table 83. New England Biolabs Glycomics & Glycobiology Products, Services and Solutions
 Table 84. Revenue (US$ Million) in Glycomics & Glycobiology Business of New England Biolabs (2020-2025)
 Table 85. New England Biolabs Recent Developments
 Table 86. Merck KGaA Basic Information List
 Table 87. Merck KGaA Description and Business Overview
 Table 88. Merck KGaA Glycomics & Glycobiology Products, Services and Solutions
 Table 89. Revenue (US$ Million) in Glycomics & Glycobiology Business of Merck KGaA (2020-2025)
 Table 90. Merck KGaA Recent Developments
 Table 91. Key Raw Materials Lists
 Table 92. Raw Materials Key Suppliers Lists
 Table 93. Glycomics & Glycobiology Downstream Customers
 Table 94. Glycomics & Glycobiology Distributors List
 Table 95. Research Programs/Design for This Report
 Table 96. Key Data Information from Secondary Sources
 Table 97. Key Data Information from Primary Sources
 Table 98. Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Glycomics & Glycobiology Product Picture
 Figure 2. Global Glycomics & Glycobiology Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Glycomics & Glycobiology Sales Value (2020-2031) & (US$ Million)
 Figure 4. Glycomics & Glycobiology Report Years Considered
 Figure 5. Global Glycomics & Glycobiology Players Revenue Ranking (2024) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Glycomics & Glycobiology Revenue in 2024
 Figure 7. Glycomics & Glycobiology Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 8. Instruments Picture
 Figure 9. Enzymes Picture
 Figure 10. Reagents Picture
 Figure 11. Kits Picture
 Figure 12. Global Glycomics & Glycobiology Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 13. Global Glycomics & Glycobiology Sales Value Market Share by Type, 2024 & 2031
 Figure 14. Product Picture of Drug Discovery & Development
 Figure 15. Product Picture of Diagnostics
 Figure 16. Product Picture of Others
 Figure 17. Global Glycomics & Glycobiology Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 18. Global Glycomics & Glycobiology Sales Value Market Share by Application, 2024 & 2031
 Figure 19. North America Glycomics & Glycobiology Sales Value (2020-2031) & (US$ Million)
 Figure 20. North America Glycomics & Glycobiology Sales Value by Country (%), 2024 VS 2031
 Figure 21. Europe Glycomics & Glycobiology Sales Value, (2020-2031) & (US$ Million)
 Figure 22. Europe Glycomics & Glycobiology Sales Value by Country (%), 2024 VS 2031
 Figure 23. Asia Pacific Glycomics & Glycobiology Sales Value, (2020-2031) & (US$ Million)
 Figure 24. Asia Pacific Glycomics & Glycobiology Sales Value by Region (%), 2024 VS 2031
 Figure 25. South America Glycomics & Glycobiology Sales Value, (2020-2031) & (US$ Million)
 Figure 26. South America Glycomics & Glycobiology Sales Value by Country (%), 2024 VS 2031
 Figure 27. Middle East & Africa Glycomics & Glycobiology Sales Value, (2020-2031) & (US$ Million)
 Figure 28. Middle East & Africa Glycomics & Glycobiology Sales Value by Country (%), 2024 VS 2031
 Figure 29. Key Countries/Regions Glycomics & Glycobiology Sales Value (%), (2020-2031)
 Figure 30. United States Glycomics & Glycobiology Sales Value, (2020-2031) & (US$ Million)
 Figure 31. United States Glycomics & Glycobiology Sales Value by Type (%), 2024 VS 2031
 Figure 32. United States Glycomics & Glycobiology Sales Value by Application (%), 2024 VS 2031
 Figure 33. Europe Glycomics & Glycobiology Sales Value, (2020-2031) & (US$ Million)
 Figure 34. Europe Glycomics & Glycobiology Sales Value by Type (%), 2024 VS 2031
 Figure 35. Europe Glycomics & Glycobiology Sales Value by Application (%), 2024 VS 2031
 Figure 36. China Glycomics & Glycobiology Sales Value, (2020-2031) & (US$ Million)
 Figure 37. China Glycomics & Glycobiology Sales Value by Type (%), 2024 VS 2031
 Figure 38. China Glycomics & Glycobiology Sales Value by Application (%), 2024 VS 2031
 Figure 39. Japan Glycomics & Glycobiology Sales Value, (2020-2031) & (US$ Million)
 Figure 40. Japan Glycomics & Glycobiology Sales Value by Type (%), 2024 VS 2031
 Figure 41. Japan Glycomics & Glycobiology Sales Value by Application (%), 2024 VS 2031
 Figure 42. South Korea Glycomics & Glycobiology Sales Value, (2020-2031) & (US$ Million)
 Figure 43. South Korea Glycomics & Glycobiology Sales Value by Type (%), 2024 VS 2031
 Figure 44. South Korea Glycomics & Glycobiology Sales Value by Application (%), 2024 VS 2031
 Figure 45. Southeast Asia Glycomics & Glycobiology Sales Value, (2020-2031) & (US$ Million)
 Figure 46. Southeast Asia Glycomics & Glycobiology Sales Value by Type (%), 2024 VS 2031
 Figure 47. Southeast Asia Glycomics & Glycobiology Sales Value by Application (%), 2024 VS 2031
 Figure 48. India Glycomics & Glycobiology Sales Value, (2020-2031) & (US$ Million)
 Figure 49. India Glycomics & Glycobiology Sales Value by Type (%), 2024 VS 2031
 Figure 50. India Glycomics & Glycobiology Sales Value by Application (%), 2024 VS 2031
 Figure 51. Glycomics & Glycobiology Industrial Chain
 Figure 52. Glycomics & Glycobiology Manufacturing Cost Structure
 Figure 53. Channels of Distribution (Direct Sales, and Distribution)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc